🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsCompounding & FormulationFDA warning letters to compounding pharmacies — November 2025 Page 5

FDA warning letters to compounding pharmacies — November 2025

gary_naperville Thu, Dec 18, 2025 at 7:46 PM 36 replies 1,552 viewsPage 5 of 8
GenomicsKate
Member
345
1,890
Oct 2024
Cambridge, MA
Dec 19, 2025 at 2:51 AM#21

Reading this thread on FDA warning letters to hits close to home. Dad of 2 checking in — I started at 281 lbs and felt like I would tried everything.

7 months on tirz and I am a different person. Not just the 56 lbs lost — my energy, my mood, my relationship with food. All transformed.

If you are on the fence about FDA warning letters — take the leap. It was the best health decision I have ever made. ❤️

Last edited: Dec 19, 2025 at 7:51 AM
5 1DebRD_ATL, KristenIndy, MarkLI_maint and 2 others
Reply Quote Save Share Report
Admin
Administrator
2,456
9,812
Oct 2023
Online
Dec 19, 2025 at 3:08 AM#22

Moderator note: Great discussion, everyone. Just a reminder to keep things civil and evidence-based.

Thread quality is excellent — keep it up. 👍

Last edited: Dec 19, 2025 at 7:08 AM
31 19SleepDoc_PDX, RegAffairsDC, BiostatsBrad and 28 others
Reply Quote Save Share Report
lucas_SP_BR
Member
456
1,890
Jun 2024
São Paulo, BR
Dec 19, 2025 at 3:25 AM#23

Relevant to FDA warning letters to — here is my latest bloodwork comparison:

Key improvements: A1C 7.6% → 5.5%, triglycerides 213 → 113 mg/dL, hsCRP 8.0 → 1.3 mg/L. All on tirzepatide for 17 months.

The inflammatory marker drop is what impresses me most. Consistent with the SELECT trial's cardiovascular findings.

Last edited: Dec 19, 2025 at 5:25 AM
5 1zoe_NC, Dr.ObesityLA, NurseKim_ATL and 2 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
lori_vegas
Member
378
1,678
Aug 2024
Las Vegas, NV
Dec 19, 2025 at 3:42 AM#24

Thank you pam_columbus! This is incredibly helpful. Taking this to my next appointment. 🙏

Last edited: Dec 19, 2025 at 5:42 AM
37 17tane_welly, Dr.PathRoch, mona_PHX and 34 others
Reply Quote Save Share Report
patPC_UT
Member
212
890
Nov 2024
Park City, UT
Dec 19, 2025 at 3:59 AM#25

+1 to AussieAnna. Especially the point about "FDA warning letters to is exactly what I..." — I have seen the same in my own experience with FDA warning letters to.

18 16julia.endo, JessicaM_2024, TomFromTexas and 15 others
Reply Quote Save Share Report

Similar Threads

503A vs 503B compounding — regulatory framework explained4 replies
Compounded semaglutide stability: accelerated degradation study results6 replies
Lyophilized vs liquid peptides — stability and bioavailability comparison18 replies
Bacteriostatic water sourcing and sterility considerations8 replies
State-by-state compounding pharmacy regulations — 2026 map8 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register